Table 2.
75 g-OGTT parameters and HDP in individuals with RBG of ≥ 100 mg/dL (n = 802)
| HDP (n = 115) | EoHDP (n = 25) | LoHDP (n = 90) | ||||
|---|---|---|---|---|---|---|
| cOR (95%CI) |
aOR§ (95%CI) |
cOR (95%CI) |
aOR§ (95%CI) |
cOR (95%CI) |
aOR§ (95%CI) |
|
| Age, years |
1.02 (0.98–1.06) |
1.00 (0.96–1.05) |
0.98 (0.90–1.05) |
0.96 (0.88–1.05) |
1.02 (0.98–1.07) |
1.02 (0.97–1.07) |
| Pre-pregnant BMI, kg/m2 |
1.16* (1.11–1.21) |
1.16* (1.11–1.21) |
1.15* (1.08–1.23) |
1.17* (1.08–1.26) |
1.13* (1.09–1.18) |
1.13* (1.08–1.19) |
| Primiparity |
1.51* (1.02–2.24) |
1.58* (1.02–2.46) |
0.99 (0.44–2.21) |
0.99 (0.42–2.32) |
1.67* (1.07–2.59) |
1.72* (1.06–2.78) |
| ART |
1.77* (1.06–2.94) |
1.99* (1.10–3.58) |
1.23 (0.41–3.66) |
1.95 (0.57–6.72) |
1.87* (1.08–3.25) |
1.88 (1.00–3.54) |
| FPG† |
1.48* (1.01–2.18) |
1.13 (0.73–1.75) |
2.10* (1.00–4.40) |
1.82 (0.81–4.08) |
1.29 (0.84–1.98) |
0.92 (0.56–1.51) |
| Initial-increase† |
1.29* (1.14–1.47) |
1.20* (1.02–1.42) |
1.22 (1.00–1.57) |
1.57* (1.15–2.15) |
1.29* (1.12–1.48) |
1.08 (0.90–1.30) |
| Subsequent-decrease† |
1.36* (1.17–1.58) |
1.12 (0.92–1.37) |
0.88 (0.65–1.18) |
0.56* (0.38–0.82) |
1.52* (1.28–1.81) |
1.38* (1.11–1.73) |
Bold values represent statistically significant
RBG random blood glucose levels, HDP hypertensive disorders of pregnancy, EoHDP early-onset HDP, LoHDP late-onset HDP, cOR crude odds ratio, aOR adjusted odds ratio, 95% CI 95% confidence interval, BMI body mass index, ART assisted reproductive technology, FPG fasting plasma glucose level
§aORs were adjusted for maternal age, pre-pregnant BMI, primiparity, ART, FPG, initial-increase, and subsequent-decrease
†per 20-mg/dL increment
*Statistically significant